Ovarian Cancer: Tinzaparin and Biomarkers

We are studying how tinzaparin affects cancer marker levels in patients with advanced ovarian cancer receiving chemotherapy. This trial also looks at the drug's safety and its impact on immune and blood factors.

6-12 monthsEfficacy phase (II)No PlaceboStandard MedicinesInjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Tinzaparin
Tinzaparin is a medicine that helps prevent and treat blood clots in the legs and lungs.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Tinzaparin
Tinzaparin is a substance that helps prevent and treat dangerous blood clots.
Tinzaparin Sodium
Tinzaparin sodium is a blood-thinning substance used to prevent and treat dangerous blood clots.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Innohep
Innohep®
Tinzaparin Sodium

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Joenkoepings Laen
Department of obestretics and gynecology
Eksjö, Sweden
Sahlgrenska University Hospital-Vaestra Goetalandsregionen
Department of oncology
Göteborg, Sweden
Region Joenkoepings Laen
Department of obestretics and gynecology
Jönköping, Sweden
Sponsor: Region Oestergoetland
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.